RSV and the common cold both cause symptoms of viral infection. Coughing tends to be more severe in RSV. Learn how RSV vs.

For years, that antibody was palivizumab, which had to be given every month throughout the RSV season to maintain immunity. This fall and winter, Ontario, Quebec and Nunavut will offer the newer ...

A different monoclonal antibody, palivizumab, is limited to children aged 24 months and younger with certain conditions that place them at high risk for severe RSV disease. But palivizumab ...

There’s also palivizumab (Synagis), the first antibody approved for use in kids against RSV. However, palivizumab is recommended only for babies who were born prematurely and are younger than six ...

RSV is the most harmful respiratory illness for young infants, says Dr. Jeffrey Pernica, a professor in the Department of ...

Respiratory Syncytial Virus (RSV) remains a critical health issue globally, particularly affecting vulnerable populations ...

AI (in this case, ChatGPT) is an amazing tool for science and medical writers. But it's not perfect. It sometimes makes ...

This fall and winter, Ontario, Quebec and Nunavut will offer the newer monoclonal antibody nirsevimab — approved by Health ...

Getting vaccinated is one of the most effective ways to protect yourself and your loved ones from the flu, COVID-19 and RSV.